Do antidepressants in pregnancy raise autism risk?

Pregnancy antidepressants and autism/ADHD risk

A large study reported that taking antidepressants during pregnancy does not increase a child’s risk of developing autism or attention-deficit/hyperactivity disorder (ADHD).

What the study concluded

Researchers analyzed more than half a million pregnancies and found no evidence that prenatal antidepressant exposure raises autism or ADHD risk. The headline takeaway is that these specific neurodevelopmental outcomes do not appear to be driven by antidepressant use during pregnancy.

Where the risk is thought to come from instead

The report indicates that if risk differences exist, they are more likely explained by other factors, including genetic predisposition to mental health conditions. In other words, shared underlying risk for both maternal mental health and later child outcomes may be a more important driver than the medication exposure itself.

Why this matters

This is clinically significant because decisions about antidepressant treatment in pregnancy often involve balancing maternal well-being against potential effects on the developing fetus.

• For patients and clinicians: the findings support reassurance around autism and ADHD risk.
• For public health messaging: it helps counter fears that have influenced medication decisions.

What remains unknown

The story doesn’t provide details on every possible medication type, dosing pattern, or other outcomes beyond autism and ADHD, so it’s best viewed as targeted evidence for those two endpoints.

Still, the scale of the dataset—over 500,000 pregnancies—gives the result high statistical power, making it a strong contribution to ongoing safety discussions for mental health care during pregnancy.